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- At the beginning of my summer of research with Dr. Brueckmann at 
Orthopaedics Indianapolis, Inc., I didn't have any idea what 
arthroplasty meant or that it was performed so frequently. As a 
result, my first weeks were filled with more questions than 
answers, and I spent a lot of time in the library reading and 
gathering information about a topic I was supposed to be an 
"expert" on by July 31, 1989. To this end, I am grateful to the 
many people at Orthopaedics Indianapolis, Inc. who patiently 
answered my questions and helped to orient me to the office: Patty 
and Marlene who gave me many pointers on successful computer usage, 
Chloe, Freda, and Karen who helped me find the many patient files 
I needed, and Susan who graciously let me share her office space. 
Also, I would like to give a BIG thank-you to Sue Wolfe whose 
optimistic and carefree attitude was a refreshing welcome everyday 
in the office. Her willingness to give her opinion and direct me 
to the right people to answer my questions proved invaluable. 
Finally, my deepest appreciation goes to Dr. F. Robert Brueckmann 
whose enthusiasm and genuine interest in all fields of medicine 
made work not seem like work at all. 
-In September, 1940, Dr. Austin Moore inserted the first 
Vitallium metal prosthesis into a human hip. aO,24 In the nearly fifty 
years since that landmark date, arthroplasty, or the replacement 
of bones and joints with prostheses, has developed considerably. 
Conventional total hip replacement, where the entire head of 
the femur and the greater trochanter are removed and the center of 
the femur shaft reamed, has been used successfully in elderly 
patients with advanced hip disease. This success is due largely 
to the sedentary activity level of these patients and the age of 
these patients, since they often die before the prothesis loosens.' 
However, younger, more active patients will most likely outlive the 
fixation of the components and will require further revisions.' For 
this reason, a more conservative total hip replacement procedure 
is recommended for younger patients. I,n A conservative procedure 
differs from conventional hip replacement in that only minimal 
portions of the femoral head and acetabulum are removed when 
implanting the prostheses. Preserving healthy bone stock not only 
provides stability to the implant, but also provides a surgical 
"buffer zone" for revisions of potential failures."u,l. This allows 
for further surgical adaptations such as arthrodesis, the fusing 
and pinning of a joint, and conventional total hip replacement to 
be performed later if necessary. 
The goal of conservative total hip arthroplasty is to minimize 
the removal of heal thy bone in the region of the hip so that 
alternative treatments can be performed in the event of failure.
' 
Total Articular Replacement Arthroplasty, or the TARA procedure, 
invented by Dr. Charles o. Townley, is one type of conservative 
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treatment which accomplishes this goal. The TARA procedure, in 
conjunction with the TARA implants, involves both arthroplasty and 
hemiarthroplasty, in which only the femoral component is implanted, 
and has been used since 1952. The major objectives of the TARA 
design are to preserve healthy bone stock, maintain the normal 
anatomy and mechanics of the hip joint, and to approximate the 
normal transmission of stress to the supporting femoral bone. J1 
(FIGURE 1) 
To reach these objecti ves, it must be determined that the 
patient has the necessary anatomical and physiological 
characteristics needed to maintain conditions for successful total 
hip arthroplasty. Several criteria, both preoperative and 
intraoperative, exist to achieve this end. (FIGURE 2) The surgeons 
involved in this study generally followed these criteria. First, 
the patient must have good bone quality as assessed from x-rays of 
the hip.' This allows for minimal bone removal during surgery and 
provides a solid base to attach the prosthesis. Also, after 
remodeling the femoral head, the bone tissue should be alive and 
healthy to ensure that further degeneration does not readily occur. 
A physiological age of less than sixty years old is a second 
criteria.' Older patients with higher activity levels also fulfill 
this criteria. The TARA procedure is highly recommended for 
younger (less than sixty years old) patients due to the 
conservative technique used and its allowance for further revisions 
upon eventual failure. However, the decision to do a total hip 
arthroplasty on a young patient must be made with the knowledge 
that the risk of eventual failure is much higher than it is for an 
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Objectives 
The TARA Design 
FIGURE 1 
• Preserve healthy bone stock 
• Maintain normal hip anatomy 
• Maintain normal hip mechanics 
• Normal transmission of stress 
to femoral bone 
c.o. Townley 
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Operative Criteria I 
• Good bone quality 
• Physiological age 
less than 60 years 
• Minimal acetabular 
reaming needed 
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indi vidual who is older than forty-f i ve years old.' A third 
cri teria is the preservation of the subchondral plate during 
acetabular reaming.' This layer of very dense bone, located just 
beneath the articulating surface of the acetabulum, endures the 
primary joint forces during weight bearing activities. By keeping 
the femoral component diameter to a minimum, only a minimal amount 
of acetabular bone stock needs to be removed, thus preserving the 
subchondral plate. By fulfilling these objectives and criteria, 
this procedure has the potential to be more effective than previous 
articular cup surfacing and fill the need for a dependable and 
conservative total hip replacement. 
The TARA procedure eliminates many of the mechanical and 
physiological factors that have led in the past to prosthesis 
failure. (FIGURE 3) First, it removes the vascularly damaged 
portion of the femoral head. 21 This reduces the potential for 
further collapse of the damaged bone since the diseased portion is 
excised prior to seating the implant in place. Second, the 
mechanical design of the TARA components provide for precise 
positioning during surgery on the femoral head and in the 
acetabulum. n The thin stem extending from the center of the cup 
curves to follow the pattern of the medullary canal in the femur. 
During weight bearing, the stem is forced to the lateral wall of 
the femoral canal, so positioning along the medial wall is 
essential to ensure that enough bone is present for stability. 
The stem also provides a protective splinting effect on the femoral 
neck, helping to reduce the risk of femoral neck fractures. ',It 
Third, the flat-planed anchoring surface reduces sheer forces and 
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TARA Surgical Procedure 
• Removes vascularly 
damaged bone 
• Precise positioning 
• Maximum mechanical stability 
• Minimal femoral reaming 
- c.o. Townley 
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provides maximum mechanical stability.a? The femoral head is 
remodeled to be cylindrical in shape, providing a fitted seat for 
the femoral prosthesis so that only the head, not the stem, bears 
the substantial joint stresses. Fourth, the design of the TARA 
femoral prosthesis does not require reaming of the femoral neck 
cortex, so this critical supportive bone is not lost." Seating the 
TARA prostheses requires only minimal bone removal on both the 
femoral and acetabular sides, and is consequently considered a 
conservative total hip replacement.' 
The purpose of the present study was to review a group of 
patients who had undergone Total Articular Replacement ArthrOplasty 
using the TARA procedure. The information gathered was used to 
determine how long after the initial operation the components could 
be expected to remain intact, to make a correlation between the age 
of the patient and the success of the prostheses, and to determine 
which component was most likely to fail. 
MATERIALS AIm METHODS 
From December 1979 through May 1989, eighty-two total 
articular replacement arthroplasties using the TARA procedure were 
performed in 62 patients. Seventy-four percent of these patients 
were seen in an office visit 
interview after January 1, 1989. 
or were followed by a telephone 
The 9.7' of the patients who had 
a failure determined by removal of the TARA components were not 
contacted since their surgery no longer involved the TARA 
procedure. The remaining 16.1' of the patients were unable to be 
contacted due to the lack of a forwarding address or telephone 
number. The average length of follow-up was 28.6 months. In the 
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-statistical analysis, it was assumed that these patients had 
successful surgeries up until the current date and that they would 
have contacted their surgeon had the pain of failure been present. 
Only three of the people contacted by telephone reported symptoms 
characteristic of failure, supporting this assumption. 
The patient group was initially identified through an office 
computer system using the current procedural terminology (CPT) 
coding system. Those patients whose surgical codes corresponded 
to arthroplasty, revision or removal of a prosthesis, cup 
arthroplasty, hemiarthroplasty, or any other total hip replacement 
which involved the TARA procedure, were included in this study. 
There were twenty-seven females and thirty-five males. The average 
age at the time of surgery was 49 years, ranging from thirteen to 
eighty years. Twenty-eight patients had involvement of the right 
hip; twenty-seven, of the left hip; and seven patients had 
bilateral involvement. The initial operations were performed by 
eight orthopaedic surgeons at Orthopaedics Indianapolis, Inc. in 
Indiana, and one orthopaedic surgeon in Michigan. 
The diagnoses of the patients can be grouped into three 
distinct categories; degenerative joint disease, avascular 
necrosis, and rheumatoid arthritis. (FIGURE 4) Forty (64.5%) of 
the patients had a diagnosis of degenerative joint disease, 
including degenerative arthritis and osteoarthritis. These 
conditions are characterized by degeneration of the joint cartilage 
and osteophyte production, which is the calcification of tendon 
tissue. They are most likely caused by advancing age and long 
_, continued use, especially in weight bearing joints. This helps to 
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INITIAL DIAGNOSIS 
Diagnosed 1979-1989 
Degener at i ve 
Join t 
65% 
Rheumatoid 
ArthritiS 
6% 
International Classification of Diseases 
Not 
Recorded 
2% 
Avascular 
~~ecrosis 
27% 
--
explain its relative frequency in obese people and in those with 
mechanical skeletal defects. 1 Degenerative joint disease is rarely 
disabling unless the hip joint is involved. l,lt Seventeen (27.4%) 
of the patients were diagnosed with avascular necrosis, including 
osteonecrosis. These conditions result when the blood supply to 
the head of the femur is limited causing bone cell death. This may 
be caused by trauma to the joint area, high corticosteroid use, 
alcoholism, renal transplant complications, lupus erythematosus, 
and a variety of other factors. lo Four (6.5%) of the patients had 
a diagnosis of rheumatoid arthritis. This is a chronic, 
progressive disease, causing pain, stiffness, muscle atrophy, and 
eventual deformity. Though the cause of rheumatoid arthritis is 
unknown, it has been linked to heredity, infection, and the 
metabolic process, among other possibilities. 1 
One (1.6%) patient's diagnosis was not recorded. 
The implants used in the TARA procedure consist of a spherical 
chrome cobalt metallic fixed femoral cup and a polyethylene 
acetabular component. 37 (FIGURE 5 , 6) They are available in eight 
matched sizes with the femoral head diameters ranging from 38 to 
54 millimeters. The inner anchoring surface of the femoral implant 
is a flat-topped cylinder which caps the remodeled femoral head. 
The acetabular implants are hemispherical cups whose inner 
diameters match the femoral heads. Some acetabular cups are 
modeled as a cock's comb cup. This design features a dual prong 
comb which is implanted into the pel vic bone to prevent the implant 
from rotating and becoming displaced. 
To fix the implants to the bone, an acrylic bone cement is 
6 
FIGURE 5 
Townley TARA 
Femoral Components 
-FIGURE 6 
Townley TARA 
Acetabular Components 
used, or porous-coated components are used to allow for biological 
fixation. Acrylic bone cement, such as polymethyl methacrylate, 
was developed in the early 1960s by Sir John Charnley.15 When used 
to cement prostheses into elderly patients, it has proven very 
successful. However, the cement is unable to sustain the higher 
stress loads endured by younger, more active adults. For this 
reason, biological fixation, or bone ingrowth fixation, is becoming 
more common. with this type of fixation, the surfaces of the 
implant which contact the bone are covered with a porous-coating. 
porous-coating consists of chrome cobalt metal beads or wire mesh 
bonded to the implant surface which increases the surface area and 
provides pores for the bone to integrate into the metal. Since the 
TARA procedure is most often used in younger adults, porous-coated 
implants are appropriate to use. In theory, porous-coating should 
allow the bone to grow into the spaces of the metal and become 
fixed without the need to use any cement. H • tS However, complications 
exist, from the metal being a suspected carcinogen, to the 
prosthesis not being fixed firmly due to the continued degeneration 
of the bone. 4.11 These compl ications have caused the FDA to 
recommend that cement be used with the implants regardless if they 
are porous-coated or not. Information concerning the use of cement 
or the acetabular cockscomb cup was not consistently recorded in 
the operative notes and thus was not included in this study. 
INCIDENCE OF FAILURE 
The overall incidence of failure was judged by walking 
ability, range of motion, and pain. Specific questions about the 
significance of pain included: the ability to walk without a cane 
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or crutches, the amount of pain medication being taken, the amount 
of range of motion available to perform daily activities, stair 
climbing ability, and pain or stiffness caused by sitting, 
standing, or walking. In order to determine failure, the following 
criteria were used. (FIGURE 7) 
1. Removed prosthesis due to mechanical failure, infection, 
or pain. 
2. Revised arthroplasty due to mechanical failure, 
infection, or pain. 
3. Significant pain interfering with the normal demands of 
daily living. 
Altogether, there were twenty procedure failures in eighteen 
patients, including pain defined failures and those requiring 
revision or prosthesis removal. This gives an overall failure rate 
of 24.4%, implying that one in every four hip replacements 
involving the TARA procedure failed when performed by one of the 
doctors involved in this study. (FIGURE 8) A vast majority of the 
failures occurred during the first three years following surgery. 
After that period, the failure rate only increased 5%, which 
greatly increases the patients' odds for a successful hip 
replacement if they can survive those first precarious years. Ten 
of the failures involved the acetabular component; eight, involved 
the femoral component; and two, involved both components. (FIGURE 
9) The average age of these patients was fifty years old, 
,- providing evidence that the younger, more active patients put more 
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FIGURE 7 
Failure Criteria 
• Removed prosthesis 
• Components revised 
• Significant pain 
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patients put more stress on the implants, inducing an increased 
chance of failure. The average length of time before these 
patients experienced prosthesis failure was 27.6 months, ranging 
from two months to one hundred months. 
It is interesting to note that more than twice as many women 
experienced failure as men, even though more men underwent surgery. 
(FIGURE 10) This may be due to the general bone quality found in 
women which tends to be softer and less able to stabilize the 
prostheses, the smaller size of the bones in females, and the 
degenerative characteristics of female bones as they age past 
menopause. This result is contradictory to previously reported 
studies. 9 ,22 Also, those patients between the ages of forty and 
sixty years old were twice as prone to failure as those patients 
over sixty years of age, and those younger than forty years of age. 
(FIGURE 11) This may be due to the lower activity level of the 
older patients, a less amount of time allowed for follow-up so that 
the procedure had not had an opportunity to fail, or the stronger 
and more dense bone stock found in the younger patients. 
According to Wolff's Law, which states that a structure adapts 
to it's function/' any modifications made during joint replacement 
cause the bone to remodel and adapt to the new stresses. If the 
initial implantation technique is poorly aligned or unstable, this 
adaptation may lead to rapid instability and failure. Thus, the 
life of fixation may be determined by the strength of the initial 
fixation, the degree of stress at the bone and implant interface, 
and the rate of bone repair.' The issue of the success of cement 
versus biological fixation using porous-coating is still being 
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debated in regards to the method of fixation. Breakdown of either 
fixation may be due to mechanical factors and applied stress. 
These involve joint forces produced by the hip musculature, the 
patient's activity level, and the patient's body weight. 
Biologically, the rate of repair is influenced by the advancing 
degenerative disease characteristics of the bone, infection, and 
hormonal and steroidal factors. 
DISCUSSION 
The incidence of failure in this study is unacceptably high, 
though it is an improvement over previously reported results 
involving total hip replacement. In other studies, including both 
conventional and conservative hip arthroplasty, the reported 
failure rates have varied widely. Generally, those studies 
invol ving the TARA procedure have produced the most promising 
results. In analyzing component failure in 67 hips with TARA 
implants, Head reported an expected failure rate of 34.3% after a 
follow-up period averaging 3.3 years. However, Townley reported 
a failure rate of only 6% in 222 hips involving the TARA procedure 
that were followed for four years. As inventor of the TARA 
procedure and the TARA prostheses, Townley's expertise is expected 
to produce such outstanding results. Cohn et al., reported a 7% 
failure rate in 33 TARA procedures followed for 3.5 to 7 years. 
This low rate is explained by the strict selection criteria Cohn 
followed when deciding which patients should undergo the TARA 
procedure. These criteria are the same as those previously 
mentioned in this report. 
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With conventional total hip replacement, the rates of failure 
reported are higher. Chandler et al., in a study involving 33 hips 
in patients younger than 30 years old, reported impending failure 
or total failure in 57% of the hips after a five year follow-up. 
Dorr et al., reported unsatisfactory results in 28% of patients who 
were less than 45 years old and were followed for over five years. 
In this study, the number of components which failed are 
almost equally divided between the femoral and acetabular sides. 
other results reported in literature show more acetabular 
complications. 13,27 It is the opinion of Townley that the use of the 
TARA fixed femoral cup for hemiarthroplasty is the best currently 
available procedure for young, active patients with a sound, 
concentric acetabulum. 27 As stated previously, the TARA femoral cup 
allows for later revision surgery if needed, it removes the 
vascularly damaged bone, the minimal femoral reaming leaves the 
healthy bone to provide support, and it's flat-topped cylinder 
shape with the thin stem design provides maximum mechanical 
stability and precise positioning. These benefits are invaluable, 
especially when the implant is used in a young patient. 
To help reduce the rate of failure, loosening of the 
components needs to be controlled and prevented. Mechanical forces 
can be reduced to reach this end. This involves proper positioning 
of the components to reduce sheer stresses and promote stability. 
Also, the surgeon could encourage the patients to keep their body 
weight low, and to avoid stressful activities such as running and 
heavy weight lifting. Other factors that may lower the failure 
rate include proper cementing technique, and removing only the 
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diseased bone I leaving the heal thy bone for support. As the 
biomechanical design of the prostheses improve and the cement 
versus porous-coat fixation debate is resolved, lower rates of 
failure should result. Excellent results can be obtained if proper 
surgical technique is adhered to and strict selection criteria is 
followed. 7 
The TARA procedure has shown to be an excellent choice for 
total hip replacement in younger patients. It's conservative 
nature not only allows for further revisions, but it uses the 
patients' youthful structural characteristics such as strong bone 
stock and minimal vascular damage to a definite advantage. It's 
immediate results in decreasing the pain and increasing the range 
of motion make the TARA procedure very satisfactory to the 
patients, an impression reflected often in the conversations shared 
by those involved in this study. 
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(Patient Data) 
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PATIENT LIST A-I 
-
CASE NUMBER PATIENT NAME PATIENT NUMBER 
1. Julia Harper (1) 103985 
2. Julia Harper (2) 103985 
3. Horace King 156531 
4. Amos Dawson (R) 234508 
5. Amos Dawson (L) 234508 
6. William Harden (1) 244929 
7. William Harden (2) 244929 
8. Ernestine King 370126 
9. Linda Youmans (hemi) 383732 
10. Linda Youmans (total) 383732 
11. Linda Youmans (revision) 383732 
12. Shanelle Erby 461660 
13. Helen Williams 466468 
14. Florence Bymaster 489077 
15. Ruth Mount (1) 508632 
16. Ruth Mount (2) 508632 
17. Gregory Dowden (hemi) 555479 
18. Gregory Dowden (total) 555479 
19. Carmen Gray 564605 
20. Harold Hendricks (1) 571016 
21. Margaret Coy 594040 
-
22. Gwendolyn Carter 628115 
23. Heidi Byers 674176 
24. Raymond Herring 704482 
25. Michael Dugan 758353 
26. Gene Horner (1) 787663 
27. Gene Horner (2) 787663 
28. Philip Carter 797022 
29. Joseph Taylor (L) 803677 
30. Joseph Taylor (R) 803677 
31. James Bogard 817074 
32. Richard Buntin 840394 
33. James Edwards 854972 
34. Patricia Budreau (L) 862142 
35. Patricia Budreau (R) 862142 
36. David Fisher 874795 
37. Norman Hughey 875872 
38. Delores Hastings (R) 880574 
39. Delores Hastings (L) 880574 
40. Martha Boleman 886793 
41. Guna Asons 887978 
42. Max Brown 888060 
43. Robert Bell 920460 
44. Patricia Yeager (1 ) 933465 
45. Patricia Yeager (2) 933465 
46. Ralph Muckerheide (R) 943959 
47. Ralph Muckerheide (L) 943959 
-
48. Ree Jean Frazee 952710 
,-
CASE HUMBER 
49. 
50. 
51. 
52. 
53. 
54. 
55. 
56. 
57. 
58. 
59. 
60. 
61. 
62. 
63. 
64. 
65. 
66. 
67. 
68. 
69. 
70. 
71. 
72. 
73. 
74. 
75. 
76. 
77. 
78. 
79. 
80. 
81. 
82. 
PATIENT LIST 
PATIENT NAME 
Kathryn Gowin 
Florence Weinman 
Louise Bowling (1) 
Louise Bowling (2) 
Louise Bowling (3) 
Ernestine White 
Kelly Million (R) 
Kelly Million (L) 
Kenton Clark 
Terry Gruenholz 
Kenneth Alles 
Alan Retherford 
Janie smith (R) 
Janie Smith (L hemi) 
Thomas Sleet (1) 
Thomas Sleet (2) 
Janett Hoke (1) 
Janett Hoke (2) 
Berneice Anderson (1) 
Berneice Anderson (2) 
George Alexander 
Max Frazee 
Jack Woody 
yvette Edmonds 
April Johnson 
Mary Veracco 
Eddie Guffey 
William Pierce 
Lyman Halverson 
Benny Lackey 
Robert Murray 
Jerry Todd 
Kenneth Chavis 
Patrick Murray 
A-2 
PATIENT NUMBER 
956694 
985759 
998990 
998990 
998990 
999245 
1000535 
1000535 
1001590 
1003356 
1016156 
1018337 
1034278 
1034278 
1070037 
1070037 
1075934 
1075934 
1087089 
1087089 
1087532 
1089596 
1089617 
1090843 
1092066 
1092513 
1093554 
1095725 
1101472 
1101839 
1105559 
1105677 
1106251 
1106340 
PATIENT STATISTICS A-3 
-- SURGERY FAIL FAILED 
CASEI SEX AGEl HIP DATE DATE3 COMP' DIAGNOSIS· 
1 \ F 28 R 12/28/79 4/28/84 acet. DJD 
2*/ F 32 R 4/28/84 
3 M 59 L 11/13/85 DJD 
4 \ M 64 R 3/16/84 DJD 
5 / M 68 L 2/23/88 
6 \ M 57 L 10/9/79 6/14/82 femr. AVN 
7*/ M 60 L 6/14/82 
8 F 66 R 12/10/86 --- DJD 
9 \ F 40 L # 8/19/80 DJD 
10 I F 41 L 1/16/81 
11*/ F 41 L 1/16/81 8/ /82 acet. 
12 F 20 L 10/21/86 1/27/89 acet. DJD 
13 F 47 R # 3/4/81 6/20/89 femr. AVN 
14 F 80 L 4/1/81 DJD 
15 \ F 62 L 12/12/80 7/13/82 acet. DJD 
16*/ F 64 L 7/13/82 DIED 1984 
17 \ M 31 R I 12/15/82 DJD 
18*/ M 32 R 8/29/84 
19 M 49 R 1/5/88 DJD 
20 M 41 R 11/13/85 11/14/88 both DJD 
21 F 61 R 10/19/84 DJD 
22 F 38 L 1/11/85 DJD 
23 F 17 L 9/22/88 AVN 
24 M 55 L 7/13/84 DJD 
25 M 44 R 3/7/89 AVN 
26 \ M 58 R 3/10/87 1/27/88 acet. DJD 
27*/ M 59 R 1/27/88 
28 M 49 R 9/10/84 DJD 
29 \ M 49 L 2/17/84 DJD 
30 / M 53 R 2/2/88 
31 M 58 R 11/29/84 DJD 
32 M 48 L 8/27/84 10/24/85 femr. DJD 
33 M 49 L # 8/10/84 DJD 
34 \ F 36 L 7/20/84 RHAR 
35 / F 38 R 1/8/86 
36 M 63 R 8/10/87 DJD 
37 M 55 R 12/27/85 DJD 
38 \ F 25 R 9/13/84 AVN 
39 / F 26 L 9/6/85 
40 F 61 L # 5/22/85 AVN 
41 F 50 L 11/15/84 DJD 
42 M 51 L # 10/26/84 AVN 
43 M 59 R # 5/19/85 9/17/86 femr. AVN 
44 \ F 56 L 12/4/85 3/30/88 acet. DJD 
45*/ F 59 L 3/30/88 
46 \ M 46 R 11/13/85 DJD 
47 / M 46 L 11/27/85 
.. ' 
- 48 F 55 R I 7/26/85 DJD 
49 F 63 R 10/18/85 1/ /89 both RHAR 
PATIENT STATISTICS A-4 
-
SURGERY FAIL FAILED 
CASE I SEX AGE HIP DATE DATE COMP DIAGNOSIS 
50 F 52 L 1/29/86 DJD 
51 \ F 46 R 2/5/86 3/26/86 acet. DJD 
52* ] F 46 R 3/26/86 11/14/86 acet. 
53*/ F 46 R 11/14/86 
54 F 57 R 4/2/86 DJD 
55 \ F 26 R # 3/30/88 AVN 
56 / F 27 L 4/5/89 
57 M 51 R 9/23/86 DJD 
58 M 36 L # 12/23/86 AVN 
59 M 31 L # 5/28/86 AVN 
60 M 50 R 5/15/86 DJD 
61 \ F 38 R # 7/21/86 AVN 
62 / F 38 L # 10/20/86 5/4/89 femr. 
63 \ M 65 R 11/25/86 5/30/89 acet. DJD 
64*/ M 67 R 5/30/89 
65 \ F 49 L 12/16/86 10/13/87 acet. DJD 
66*/ F 50 L 10/13/87 
67 \ F 74 R 1982 1983 femr. RHAR 
68*/ F 75 R 1983 4/7/87 femr. 
69 M 70 L 3/22/88 DJD 
70 M 70 R 7/17/87 DJD 
71 M 53 R 1980 UNK 
72 F 27 L # 9/29/87 6/19/89 femr. AVN 
73 F 16 R # 10/20/87 AVN 
74 F 55 R 1/3/89 DJD 
75 M 19 L 2/16/89 AVN 
76 M 65 L 4/26/88 DJD 
77 M 34 L # 9/6/88 AVN 
78 M 13 L # 9/28/88 DJD 
79 M 34 R # 2/28/89 DJD 
80 M 53 L 5/24/89 DJD 
81 M 17 L 5/31/89 AVN 
82 M 36 R 3/28/89 RHAR 
* indicates revision of a TARA procedure surgery 
\ indicates patients who have undergone multiple TARA surgeries 
/ 
# indicates hemiarthroplasty (femoral prosthesis) surgery only 
-A-S 
1. Age at time of surgery 
2. Date revision surgery was needed as a result of significant 
pain or prosthesis loosening. 
3. Prosthesis, acetabular, femoral, or both, which was causing the 
pain of failure or was revised due to loosening. 
4. Diagnosis of hip disease at time of surgery. 
AVN - Avascular Necrosis 
- osteonecrosis 
DJD - Degenerative Arthritis 
- Degenerative Joint Disease 
- osteoarthritis 
RHAR - Rheumatoid Arthritis 
UNK - Unknown 
PATIENT STATISTICS A-6 
,.-
SURGERY FAIL FAIL SlIFS3 
CASE' SEX AGr HIP DATE DATE2 TIME) TIME' 
1 \ F 28 R 12/28/79 4/28/84 52 
2*/ F 32 R 4/28/84 62 
3 M 59 L 11/13/85 20 
4 \ M 64 R 3/16/84 61 
5 / M 68 L 2/23/88 14 
6 \ M 57 L 10/9/79 6/14/82 32 
7*/ M 60 L 6/14/82 50 
8 F 66 R 12/10/86 29 
9 \ F 40 L 8/19/80 24 
10 F 41 L 1/16/81 19 
11*/ F 41 L 1/16/81 8/ /82 19 
12 F 20 L 10/21/86 1/27/89 27 
13 F 47 R 3/4/81 6/20/89 100 
14 F 80 L 4/1/81 99 
15 \ F 62 L 12/12/80 7/13/82 19 
16*/ F 64 L 7/13/82 DIED 1984 24 
17 \ M 31 R 12/15/82 76 
18*/ M 32 R 8/29/84 56 
19 M 49 R 1/5/88 18 
20 M 41 R 11/13/85 11/14/88 36 
21 F 61 R 10/19/84 56 
-
22 F 38 L 1/11/85 10 
23 F 17 L 9/22/88 7 
24 M 55 L 7/13/84 60 
25 M 44 R 3/7/89 2 
26 \ M 58 R 3/10/87 1/27/88 10 
27*/ M 59 R 1/27/88 12 
28 M 49 R 9/10/84 33 
29 \ M 49 L 2/17/84 60 
30 / M 53 R 2/2/88 13 
31 M 58 R 11/29/84 55 
32 M 48 L 8/27/84 10/24/85 14 
33 M 49 L 8/10/84 8 
34 \ F 36 L 7/20/84 58 
35 / F 38 R 1/8/86 40 
36 M 63 R 8/10/87 22 
37 M 55 R 12/27/85 5 
38 \ F 25 R 9/13/84 58 
39 / F 26 L 9/6/85 46 
40 F 61 L 5/22/85 49 
41 F 50 L 11/15/84 55 
42 M 51 L 10/26/84 52 
43 M 59 R 5/19/85 9/17/86 16 
44 \ F 56 L 12/4/85 3/30/88 28 
45*/ F 59 L 3/30/88 15 
46 \ M 46 R 11/13/85 40 
47 / M 46 L 11/27/85 39 
,- 48 F 55 R 7/26/85 9 
49 F 63 R 10/18/85 1/ /89 38 
~- PATIENT STATISTICS A-7 
SURGERY FAIL FAIL SII'JiSS 
CASE , SEX AGE HIP DATE DATE TIME TIME 
50 F 52 L 1/29/86 36 
51 \ F 46 R 2/5/86 3/26/86 2 
52* ] F 46 R 3/26/86 11/14/86 8 
53*/ F 46 R 11/14/86 31 
54 F 57 R 4/2/86 35 
55 \ F 26 R 3/30/88 13 
56 / F 27 L 4/5/89 1 
57 M 51 R 9/23/86 10 
58 M 36 L 12/23/86 10 
59 M 31 L 5/28/86 32 
60 M 50 R 5/15/86 37 
61 \ F 38 R 7/21/86 35 
62 / F 38 L 10/20/86 5/4/89 30 
63 \ M 65 R 11/25/86 5/30/89 30 
64*/ M 67 R 5/30/89 1 
65 \ F 49 L 12/16/86 10/13/87 10 
66*/ F 50 L 10/13/87 3 
67 \ F 74 R 1982 1983 12 
68*/ F 75 R 1983 4/7/87 48 
69 M 70 L 3/22/88 23 
70 M 70 R 7/17/87 24 
-. 71 M 53 R 1980 96 
72 F 27 L 9/29/87 6/19/89 21 
73 F 16 R 10/20/87 20 
74 F 55 R 1/3/89 4 
75 M 19 L 2/16/89 3 
76 M 65 L 4/26/88 6 
77 M 34 L 9/6/88 4 
78 M 13 L 9/28/88 6 
79 M 34 R 2/28/89 2 
80 M 53 L 5/24/89 1 
81 M 17 L 5/31/89 1 
82 M 36 R 3/28/89 2 
* indicates revision of a TARA procedure surgery 
\ indicates patients who have undergone multiple TARA surgeries 
/ 
.. -
A-8 
1. Age at time of surgery 
2. Date revision surgery was needed as a result of significant 
pain or prosthesis loosening. 
3. Time, in months, from surgery until revision was needed or 
failure was determined. 
4. Time, in months, from date of TARA surgery until most recent 
follow-up visit. (after January 1, 1989) 
-PATIENT STATISTICS A-9 
SURGERY FAIL LAST 
CASEI SEX AG~ HIP DATE DAT~ DAT~ DOCTOR· 
1 \ F 28 R 12/28/79 4/28/84 FRS 
2*/ F 32 R 4/28/84 6/20/89 FRS 
3 M 59 L 11/13/85 7/21/87 FRB 
4 \ M 64 R 3/16/84 4/28/89 ARL 
5 / M 68 L 2/23/88 4/28/89 FRS 
6 \ M 57 L 10/9/79 6/14/82 FRS 
7*/ M 60 L 6/14/82 9/4/86 FRB 
8 F 66 R 12/10/86 4/27/89 FRB 
9 \ F 40 L 8/19/80 COT 
10 I F 41 L 1/16/81 COT 
11*/ F 41 L 1/16/81 8/ /82 COT 
12 F 20 L 10/21/86 1/27/89 1/27/89 FRS 
13 F 47 R 3/4/81 6/20/89 6/20/89 DER 
14 F 80 L 4/1/81 6/20/89 WOI 
15 \ F 62 L 12/12/80 7/13/82 WOI 
16*/ F 64 L 7/13/82 DIED 1984 WOI 
17 \ M 31 R 12/15/82 4/28/89 DER 
18*/ M 32 R 8/29/84 4/28/89 DER 
19 M 49 R 1/5/88 6/21/89 FRS 
20 M 41 R 11/13/85 11/14/88 5/16/89 JCR 
21 F 61 R 10/19/84 6/19/89 DER 
22 F 38 L 1/11/85 11/11/85 FRS 
23 F 17 L 9/22/88 5/5/89 FRS 
24 M 55 L 7/13/84 6/20/89 ARL 
25 M 44 R 3/7/89 5/4/89 FRS 
26 \ M 58 R 3/10/87 1/27/88 2/2/89 FRB 
27*/ M 59 R 1/27/88 2/2/89 FRS 
28 M 49 R 9/10/84 6/5/87 DER 
29 \ M 49 L 2/17/84 3/2/89 FRS 
30 / M 53 R 2/2/88 3/2/89 FRS 
31 M 58 R 11/29/84 7/6/89 FRS 
32 M 48 L 8/27/84 10/24/85 2/22/89 DER 
33 M 49 L 8/10/84 4/18/85 ARL 
34 \ F 36 L 7/20/84 5/15/89 FRS 
35 / F 38 R 1/8/86 5/15/89 FRS 
36 M 63 R 8/10/87 6/20/89 FRS 
37 M 55 R 12/27/85 5/19/86 FRS 
38 \ F 25 R 9/13/84 7/6/89 FRB 
39 / F 26 L 9/6/85 7/6/89 FRS 
40 F 61 L 5/22/85 6/19/89 FRB 
41 F 50 L 11/15/84 6/19/89 FRS 
42 M 51 L 10/26/84 2/16/89 FRS 
43 M 59 R 5/19/85 9/17/86 FRS 
44 \ F 56 L 12/4/85 3/30/88 FRS 
45*/ F 59 L 3/30/88 6/30/89 FRS 
46 \ M 46 R 11/13/85 3/9/89 FRS 
,- 47 / M 46 L 11/27/85 3/9/89 FRS 
48 F 55 R 7/26/85 4/28/86 FRB 
-PATIENT STATISTICS A-10 
SURGERY FAIL LAST 
CASE I SEX AGE HIP DATE DATE DATE DOCTOR 
49 F 63 R 10/18/85 1/ /89 6/20/89 ARL 
50 F 52 L 1/29/86 1/23/89 FRS 
51 \ F 46 R 2/5/86 3/26/86 6/22/89 JCR 
52* ] F 46 R 3/26/86 11/14/86 6/22/89 JCR 
53*/ F 46 R 11/14/86 6/22/89 COT 
54 F 57 R 4/2/86 3/6/89 FRS 
55 \ F 26 R 3/30/88 5/4/89 FRB 
56 / F 27 L 4/5/89 5/4/89 FRS 
57 M 51 R 9/23/86 7/13/87 FRS 
58 M 36 L 12/23/86 10/12/87 FRS 
59 M 31 L 5/28/86 1/16/89 FRS 
60 M 50 R 5/15/86 6/20/89 FRS 
61 \ F 38 R 7/21/86 6/12/89 MRS 
62 / F 38 L 10/20/86 5/4/89 6/12/89 DER 
63 \ M 65 R 11/25/86 5/30/89 5/30/89 FRS 
64*/ M 67 R 5/30/89 5/30/89 FRB 
65 \ F 49 L 12/16/86 10/13/87 FRS 
66*/ F 50 L 10/13/87 1/14/88 FRS 
67 \ F 74 R 1982 1983 COT 
68*/ F 75 R 1983 4/7/87 COT 
69 M 70 L 3/22/88 6/19/89 FRS 
- 70 M 70 R 7/17/87 7/6/89 FRS 
71 M 53 R 1980 7/21/88 COT 
72 F 27 L 9/29/87 6/19/89 6/19/89 FRS 
73 F 16 R 10/20/87 6/21/89 FRS 
74 F 55 R 1/3/89 5/15/89 FRB 
75 M 19 L 2/16/89 5/8/89 JKS 
76 M 65 L 4/26/88 11/7/88 FRS 
77 M 34 L 9/6/88 1/16/89 FRS 
78 M 13 L 9/28/88 4/6/89 FRB 
79 M 34 R 2/28/89 4/27/89 FRB 
80 M 53 L 5/24/89 6/6/89 FRS 
81 M 17 L 5/31/89 6/13/89 DAF 
82 M 36 R 3/28/89 5/17/89 FRB 
* indicates revision of a TARA procedure surgery 
\ indicates patients who have undergone multiple TARA surgeries 
/ 
A-11 
1. Age at time of surgery 
2. Date revision surgery was needed as a result of significant 
pain or prosthesis loosening. 
3. Date patient was last seen in an office visit or was contacted 
by telephone for follow-up. 
4. Name of the doctor who performed the surgery. All of the 
doctors were employed at Orthopaedics Indianapolis, Inc. at that 
time except for Dr. Townley of Port Huron, Michigan. 
FRB Dr. F. Robert Brueckmann 
OAF Dr. David A. Fisher 
WOI Dr. William o. Irvine 
ARL Dr. Anthony R. Lasich 
JCR Dr. Joseph C. Randolph 
DER Dr. Donald E. Russell 
JKS Dr. John K. Schneider 
MRS Dr. Mark R. stevens 
COT Dr. Charles o. Townley 
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APPENDIX B 
,.-
(Speech Text) 
.-
-
SLIDE 1--TITLE 
SLIDE 2--JOINT ANATOMY 
In September, 1940, Dr. Austin Moore inserted the first metal 
prosthesis into a human hip.~'~ In the nearly fifty years since 
that landmark date, arthroplasty, or the replacement 0f bones and 
joints with prostheses, has developed considerably. 
Conventional total hip replacement, where the entire head of 
the femur and the greater trochanter are removed and the center of 
the femur shaft reamed, has been used successfully in elderly 
patients with advanced hip disease. This success is due largely 
to the sedentary activity level of these patients and the age of 
these patients, since they often die before the prothesis loosens.' 
However, younger, more active patients will most likely outlive the 
fixation of the components and will require further revisions. 6 For 
this reason, a more conservative total hip replacement procedure 
is recommended for younger patients. 5,13 
Total Articular Replacement Arthroplasty, or 
procedure, invented by Dr. Charles Townley, is one 
conservative treatment and has been used since 1952. 
SLIDE 3--0BJECTIVES 
the TARA 
type of 
The major objectives of the TARA design are to preserve 
healthy bone stock, maintain the normal anatomy and mechanics of 
the hip joint, and to approximate the normal transmission of stress 
to the supporting femoral bone. 27 
1 
,- SLIDE 4--SURGERY 
The TARA procedure eliminates many of the mechanical and 
physiological factors that have led in the past to prosthesis 
failure. First, it removes the vascularly damaged portion of the 
femoral head. 27 This reduces the potential for further collapse of 
the damaged bone since the diseased portion is excised prior to 
seating the implant in place. Second, the mechanical design of the 
TARA components provide for precise positioning during surgery. 27 
The thin stem extending from the center of the cup provides a 
protective splinting effect on the femoral neck, helping to reduce 
the risk of femoral neck fractures. I,U Third, the flat-planed 
anchoring surface reduces sheer forces and provides maximum 
mechanical stability. 27 The femoral head is remodeled to be 
- cylindrical in shape, providing a fitted seat for the femoral 
prosthesis so that only the head, not the stem, bears the 
substantial joint stresses. Fourth, the design of the TARA femoral 
prosthesis does not require reaming of the femoral neck cortex, so 
this critical supportive bone is not lost. 27 
The purpose of the present study was to review a group of 
patients who had undergone Total Articular Replacement Arthroplasty 
using the TARA procedure. The information gathered was used to 
determine how long after the initial operation the components could 
be expected to remain intact, and to make a correlation between the 
age of the patient and the success of the prostheses. 
2 
,- MATERIALS ABD METHODS 
From December 1979 through May 1989, eighty-two TARA 
procedures were performed in 62 patients. Those patients whose 
surgery involved arthroplasty, revision or removal of a prosthesis, 
cup arthroplasty, hemiarthroplasty, or any other total hip 
replacement which involved the TARA procedure, were included in 
this study. These patients were seen in an office visit or were 
followed by a telephone interview after January 1, 1989. The 
average length of follow-up was 28.6 months. There were twenty-
seven females and thirty-five males. The average age at the time 
of surgery was 49 years, ranging from thirteen to eighty years. 
Twenty-eight patients had involvement of the right hip: twenty-
seven, of the left hip; and seven patients had bilateral 
invol vement. The ini tial operations were performed by eight 
orthopaedic surgeons at Orthopaedics Indianapolis, Inc. in Indiana, 
and one orthopaedic surgeon in Michigan. 
SLIDE 5--DIAGNOSIS 
The diagnoses of the patients can be grouped into three 
distinct categories: degenerative joint disease, avascular 
necrosis, and rheumatoid arthritis. 64.5% of the patients had a 
diagnosis of degenerative joint disease, characterized by 
degeneration of the joint cartilage. This is most likely caused 
by advancing age and long continued use, especially in weight 
bearing joints. Degenerative joint disease is rarely disabling 
unless the hip joint is involved. 1,19 27.4% of the patients were 
diagnosed with avascular necrosis. This condition results when the 
3 
blood supply to the head of the femur is limited causing bone cell 
death, and may be caused by trauma to the joint area, high 
corticosteroid use, alcoholism, renal transplant complications, 
lupus erythematosus, and a variety of other factors. 1o 6.5% of the 
patients had a diagnosis of rheumatoid arthritis. This is a 
chronic, progressi ve disease, 
atrophy, and eventual deformity. 
causing pain, stiffness, muscle 
The cause of rheumatoid arthritis 
has been linked to heredity, infection, and the metabolic process, 
among other possibilities. 1 One (1.6%) patient's diagnosis was not 
recorded. 
SLIDES 6-11--COMPONENTS 
The implants used in the TARA procedure consist of a spherical 
chrome cobalt femoral cup and a polyethylene acetabular component. 27 
The inner anchoring surface of the femoral implant is a flat-topped 
cylinder which caps the remodeled femoral head. The acetabular 
implants are hemispherical cups whose inner diameters match the 
femoral heads. 
SLIDE 12--INGROWTH 
To fix the implants to the bone, an acrylic bone cement is 
used, or porous-coated components are used to allow for biological 
fixation. Porous-coating consists of chrome cobalt metal beads 
bonded to the implant surface which increases the surface area and 
provides pores for the bone to grow into the metal and become fixed 
wi thout the need to use any cement. 11,15 
4 
INCIDENCE OF FAILURE 
SLIDE 13--CRITERIA 
In order to determine failure, the following criteria were 
used. 
1. Removed prosthesis 
2. components revised 
3. significant pain 
Specific questions about the significance of pain included: 
the ability to walk without a cane or crutches, the amount of pain 
medication being taken, the amount of range of motion available 
to perform daily activities, stair climbing ability, and pain or 
stiffness caused by sitting, standing, or walking. 
SLIDE 14--RATE 
Altogether, there were twenty procedure failures in eighteen 
patients. This gives an overall failure rate of 24.4%, implying 
that one in every four hip replacements involving the TARA 
procedure failed when performed by one of the doctors involved in 
this study. A vast majority of the failures occurred during the 
first three years following surgery. 
SLIDE 15--IMPLANTS 
Ten of the failures involved the acetabular component; eight, 
involved the femoral component; and two, involved both components. 
The average age of these patients was fifty years old, providing 
evidence that the younger, more active patients put more stress on 
the implants, inducing an increased chance of failure. The average 
length of time before these patients experienced prosthesis failure 
5 
was 27.6 months, ranging from two months to one hundred months. 
SLIDE 16--GENDER 
It is interesting to note that more than twice as many women 
experienced failure as men, even though more men underwent surgery. 
This may be due to the smaller size of bones in females, the 
degenerative characteristics of female bones as they age past 
menopause, and the general softer bone quality found in females 
which is unable to stabilize the prostheses. 
contradictory to previously reported studies. 9,22 
SLIDE 17--AGE 
This result is 
Also, those patients between the ages of forty and sixty years 
of age were twice as prone to failure as those patients older than 
sixty or younger than forty years of age. This may be due to the 
lower activity level of the older patients, a less amount of time 
allowed for follow-up so that the procedure had not had an 
opportuni ty to fail, or the stronger and more dense bone stock 
found in the younger patients. 
DISCUSSION 
The incidence of failure in this study is unacceptably high, 
though it is an improvement over previously reported results 
involving total hip replacement. In other studies, including both 
conventional and conservative hip arthroplasty, the reported 
failure rates have varied widely. Generally, those studies 
involving the TARA procedure have produced the most promising 
results. 
To help reduce the rate of failure, loosening of the 
6 
~-
components needs to be controlled and prevented. Mechanical forces 
can be reduced to reach this end. Joint forces produced by the hip 
musculature, the patient's activity level, and the patient's body 
weight may lead to a breakdown in the fixation of the components. 
Limiting these forces, and proper positioning and cementing of the 
components may help to promote stability. Biologically, loosening 
may be influenced by the advancing degenerative disease 
characteristics of the bone, infection, and hormonal and steroidal 
factors. As the biomechanical design of the prostheses improve and 
the cement versus porous-coat fixation debate is resolved, lower 
rates of failure should result. Excellent results can be obtained 
if proper surgical technique is adhered to and strict selection 
criteria is followed.' 
The TARA procedure has shown to be an excellent choice for 
total hip replacement in younger patients. It's conservative 
nature not only allows for further revisions, but it uses the 
patients' youthful structural characteristics such as strong bone 
stock and minimal vascular damage to a definite advantage. It's 
immediate results in decreasing the pain and increasing the range 
of motion make the TARA procedure very satisfactory to the 
patients, an impression reflected often in the conversations shared 
by those involved in this study. 
7 
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